Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Oct-6 transcriptional factor a possible biomarker for leprosy diagnosis

Serrano-Coll H, Salazar-Peláez LM, Mesa-Betancourt F, et al. Elsevier BV. Diagnostic Microbiology and Infectious Disease. 2020;
Publication

Report of a Leprosy case in Singapore: an age-old disease not to be forgotten in developed countries with low-prevalence settings.

Tan YE, Yeo YW, Ang DJQ, et al. Access microbiology. 2019; 1 (3) : e000014.
Download PDF
Publication

Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options.

Mungroo M, Khan N, Siddiqui R. Microbial pathogenesis. 2020;
Publication

Chemical Synthesis of the Trisaccharide Epitope of Phenolic Glycolipid-1 Surface Antigen from Mycobacterium leprae.

Luo W, Lu B, Zhou R, et al. The Journal of organic chemistry. 2020; 85 (16) : 10973-10979.
Publication

Typology and pathogenesis of neuropathic pain with leprosy

Belopasov V V. Russian Medical Review. 2018;
Download PDF
Publication

The role of an active surveillance strategy of targeting household and neighborhood  contacts related to leprosy cases released from treatment in a low-endemic area of China.

Wang N, Chu T, Li F, et al. PLoS neglected tropical diseases. 2020; 14 (8) : e0008563.
Download PDF
Publication

Diagnóstico da rede de atendimento laboratorial de hanseníase no Departamento Regional de Saúde XV, São José do Rio Preto, São Paulo

Modesto Tolentino Binhardi F, Nardi SMT, Dos Santos Patine F, et al. FapUNIFESP (SciELO). 2020;
Download PDF
Publication

Peripheral nerve biopsy: a tool still needed in the early diagnosis of neural leprosy?

Santos D, Antunes D, Dornelas B, et al. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2020;
Publication

Leprosy (Hansen Disease)

Bhandari J, Awais M, Gupta V. StatPearls Publishing. 2020;
Download PDF
Publication

Pure Neuritic Leprosy : A Series of Three Cases

Kale , Gadgil N, Chaudhari C. Indian J Lepr.. 2020;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 84
  • Next page ››
Subscribe to Diagnosis

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD